MedTrace Logo

The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.

NCT00151905 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2007-05-07

No results posted yet for this study

Summary

Bronchiolitis is a common viral lung infection in infants. Standard treatment often includes the use of inhaled medications which are usually first mixed with a standard salt solution. Inhalation of a more concentrated salt solution (hypertonic saline) has been successfully used to treat other types of lung disease in children and adults. The purpose of this study is to see if using inhaled hypertonic saline helps infants with bronchiolitis get better more quickly.

Conditions

  • Bronchiolitis

Interventions

DRUG

3 % hypertonic saline

Sponsors & Collaborators

  • Sheikh Khalifa Medical City

    lead OTHER

Principal Investigators

  • Brian A Kuzik, MD, FRCP · Sheikh Khalifa Medical City

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2006-09-30

Countries

  • Canada
  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00151905 on ClinicalTrials.gov